Latest Breaking News On - Gt medical technologies inc - Page 3 : comparemela.com

GT Medical Technologies, Inc Nominated for Prix Galien USA 2023 Award by Galien Foundation in Best Medical Device Category for Company s GammaTile® Therapy

GT Medical Technologies, Inc Nominated for Prix Galien USA 2023 Award by Galien Foundation in Best Medical Device Category for Company s GammaTile® Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAmerican museum of natural historyLori kaganGalien foundationAward for best medical technologyGt medical technologies incDawn communicationsPrix galien united statesBest medical technologyAmerican museumNatural historyTile therapySurgically targeted radiation therapyGammatile therapy

GT Medical Technologies, Inc GammaTile® Therapy Awarded

GT Medical Technologies, Inc GammaTile® Therapy Awarded
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesHalf moon bayBritish columbiaLori kaganTechnologie gammatileGt medical technologies incPrnewswire gt medical technologies incDawn communicationsGt medical technologies inc gammatilePromising new productMedical deviceDiagnostic conferenceChief executivePhoenix conferenceSurgically targeted radiation therapyAnnual phoenix conference

Gammatile shows well at four months in patients with recurrent metastases

Patients with metastatic brain tumors are among the most desperate of patients for at least a modestly effective treatment let alone a cure, and GT Medical Technologies Inc., of Tempe, Ariz., reported the interim findings from a study of 48 patients suffering from a total of 51 brain metastases. Four-month data from this study demonstrate that implant of the Gammatile device is safe as demonstrated by the lack of adverse events, and these results combined with other data suggest that this device can offer this patient population real hope of surviving one of the deadliest series of afflictions known to humankind.

Gt medical technologies incTechnologies incGt medical technologies incBrain tumors

Multi-Institutional Study Data Presented at ASTRO 2023 Builds Upon Growing Evidence of GammaTile for Patients with Brain Tumors

GT Medical Technologies, Inc. announced interim findings of a multi-institutional study that demonstrates high local control for the treatment of recurrent brain metastases in patients. The findings were presented during the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023, being held this week in San Diego, CA.

San diegoUnited statesRupesh kotechaMarkj amsbaughDavid brachmanCatherines kimBaptist health south floridaMiami cancer instituteBarrow neurological instituteGt medical technologies incNational library of medicineMemorial sloan cancer centerAmerican society for radiation oncologyGammatile therapyAmerican societyRadiation oncology

GT Medical Technologies, Inc Presents New Data Further Demonstrating High Local Control for the Treatment of Recurrent Brain Metastases at the ASTRO 2023 Annual Meeting

/PRNewswire/ GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced interim.

United statesCatherines kimRupesh kotechaMarkj amsbaughLori kaganDavid brachmanSan diego convention centerBaptist health south floridaMemorial sloan cancer centerNational library of medicinePrnewswire gt medical technologies incMiami cancer instituteGt medical technologies incAmerican society for radiation oncologyDawn communicationsBarrow neurological institute